A trial of a virtual reality treatment to improve social functioning in young people experiencing hallucinations

Not Applicable

• Conditions: Early psychosis; Schizophrenia; Mental Health - Schizophrenia

• Registration Number: ACTRN12624000136505
• Lead Sponsor: The Royal Melbourne Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-02-14
• Last Update Posted: 19 February 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1) Any service users aged 16-25 within an early psychosis or ultra-high risk for psychosis service who are experiencing current hallucinations, defined by the occurrence of sensory experience in the absence of external stimuli, occurring at least once in the past month
2) The hallucinations are interfering with social functioning, as reported by the young person and/or clinician

Exclusion Criteria

1) Inability to communicate via English language
2) Recent change in mental health treatment, including new medication or initiation of psychological therapy within last 8 weeks
3) Moderate or severe intellectual disability as determined by the treating clinician
4) Moderate or severe audio or visual condition precluding engagement with the VR equipment
5) Current risk of harm to self or others, as judged by treating clinician
6) Current inpatient of a psychiatric hospital

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility - recruitment and consent rates[ Via audit of study enrolment and consent logs 12 weeks post intervention commencement ];Acceptability - intervention endorsement [Proportion of respondents who state they would recommend the intervention to other young people, measured using a purpose built self-report acceptability questionnaire 12 weeks post intervention commencement ];Safety - adverse events [The number of adverse events and serious adverse events specifically related to the intervention or trial (e.g. nausea during VR) via post session log book Continuously throughout the trial and at 12 weeks post intervention]